Seriant

CROPublic Company
Montreal, Canada
Website
2001
Founded
50-200
Employees

About Seriant

In 2025, the MHICC became Seriant to reflect our commitment to driving transformation across a wider range of therapeutic areas. We continue to expand our reach beyond cardiology, helping shape the future of clinical research in precision medicine, metabolic disorders, oncology and more. By broadening our scope, we continue to create meaningful impacts through clinical research that reach people around the world. At Seriant, we drive your clinical studies forward with precision, agility, and unwavering commitment. Through expert leadership, specialized technology, and seamless collaboration, we ensure every trial advances efficiently toward success. Whether through large-scale clinical trials or smaller, pivotal studies, we are committed to advancing knowledge and improving patient outcomes, across therapeutic areas, for pharmaceuticals and medical devices.

Services

Protocol and Study DesignSite ManagementVendor Selection and Strategic OutsourcingStartup Services and Site ManagementData Sources and Data ManagementBiostatistics, Trial Support SoftwareAdverse Event ManagementClinical Study ReportMeetingsQuality Assurance/Risk Management

Therapeutic areas

Genetic DisordersCNS/NeurologyOncologyCardiologyGastroenterologyImmunologyInfectious DiseasesMetabolism and Endocrinology

Experience & capabilities

Trial phases:Phase 1Phase 2Phase 3Phase 4
Products:Therapeutic productsMedical DevicesDiagnostics
Trial geography:GlobalNorth AmericaEuropeCentral AmericaMiddle EastSoutheast AsiaAfrica
Languages:EnglishFrench

Team

  • Axel BergmanDirector, Business DevelopmentLinkedIn
  • Melissa StremelDirector of OperationsLinkedIn
  • Sophie TanguayExecutive DirectorLinkedIn

Browse companies by location

Montreal, CanadaCanada

Similar CRO companies in Canada

London, Canada·500-5,000 employees

Axon

CRO
montreal, Canada·500-5,000 employees
Montreal, Canada·50-200 employees